Eli Lilly and Company
MX ˙ BMV ˙ US5324571083
SecurityMX:LLY / Eli Lilly and Company
InstitutionDearborn Partners Llc
Latest Disclosed Ownership4,511 shares
Latest Disclosed Value $ 4,149,082
Dearborn Partners Llc reports 4.81% increase in ownership of LLY / Eli Lilly and Company

On May 12, 2026 - Dearborn Partners Llc filed a 13F-HR form disclosing ownership of 4,511 shares of Eli Lilly and Company (MX:LLY) valued at $4,149,082 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 4,304 shares of Eli Lilly and Company. This represents a change in shares of 4.81% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F Eli Lilly COM 532457108 4,511 207 4.81 4,149 -10.29 0.2170
2026-02-11 2025-12-31 13F Eli Lilly COM 532457108 4,304 -382 -8.15 4,625 29.37 0.2310
2025-11-10 2025-09-30 13F Eli Lilly COM 532457108 4,686 -186 -3.82 3,575 -5.85 0.1676
2025-08-14 2025-06-30 13F Eli Lilly COM 532457108 4,872 -250 -4.88 3,798 -10.24 0.1798
2025-05-08 2025-03-31 13F Eli Lilly COM 532457108 5,122 180 3.64 4,230 10.88 0.2031
2025-02-07 2024-12-31 13F Eli Lilly COM 532457108 4,942 239 5.08 3,815 -8.43 0.1599
2024-11-06 2024-09-30 13F Eli Lilly COM 532457108 4,703 55 1.18 4,167 -1.00 0.1691
2024-07-26 2024-06-30 13F Eli Lilly COM 532457108 4,648 37 0.80 4,208 17.31 0.1820
2024-05-08 2024-03-31 13F Eli Lilly COM 532457108 4,611 -66 -1.41 3,587 31.58 0.1540
2024-01-26 2023-12-31 13F Eli Lilly COM 532457108 4,677 131 2.88 2,726 11.68 0.0993
2023-11-01 2023-09-30 13F Eli Lilly COM 532457108 4,546 -134 -2.86 2,442 11.26 0.0958
2023-08-03 2023-06-30 13F Eli Lilly COM 532457108 4,680 45 0.97 2,195 37.90 0.0840
2023-05-04 2023-03-31 13F Eli Lilly COM 532457108 4,635 55 1.20 1,592 -5.01 0.0626
2023-02-02 2022-12-31 13F Eli Lilly COM 532457108 4,580 -128 -2.72 1,676 10.05 0.0676
2022-11-21 2022-09-30 13F/A-1 Eli Lilly COM 532457108 4,708 128 2.79 1,522 2.49 0.0671
2022-10-25 2022-09-30 13F Eli Lilly COM 532457108 4,708 128 1,522 0.0627
2022-07-20 2022-06-30 13F Eli Lilly COM 532457108 4,580 100 2.23 1,485 15.74 0.0627
2022-05-04 2022-03-31 13F Eli Lilly COM 532457108 4,480 -14 -0.31 1,283 3.38 0.0487
2022-01-28 2021-12-31 13F Eli Lilly COM 532457108 4,494 0 0.00 1,241 19.56 0.0450
2021-10-27 2021-09-30 13F Eli Lilly COM 532457108 4,494 6 0.13 1,038 0.78 0.0422
2021-07-26 2021-06-30 13F Eli Lilly COM 532457108 4,488 0 0.00 1,030 22.91 0.0414
2021-04-29 2021-03-31 13F Eli Lilly COM 532457108 4,488 135 3.10 838 14.01 0.0357
2021-01-27 2020-12-31 13F Eli Lilly COM 532457108 4,353 525 13.71 735 29.63 0.0335
2020-10-20 2020-09-30 13F Eli Lilly COM 532457108 3,828 -349 -8.36 567 -17.35 0.0282
2020-07-30 2020-06-30 13F Eli Lilly COM 532457108 4,177 24 0.58 686 19.10 0.0371
2020-05-11 2020-03-31 13F Eli Lilly COM 532457108 4,153 667 19.13 576 25.76 0.0357
2020-01-28 2019-12-31 13F Eli Lilly COM 532457108 3,486 0 0.00 458 17.44 0.0233
2019-10-29 2019-09-30 13F Eli Lilly COM 532457108 3,486 -27 -0.77 390 0.26 0.0226
2019-07-29 2019-06-30 13F Eli Lilly COM 532457108 3,513 -269 -7.11 389 -20.77 0.0238
2019-05-01 2019-03-31 13F Eli Lilly COM 532457108 3,782 0 0.00 491 12.10 0.0328
2019-02-04 2018-12-31 13F Eli Lilly COM 532457108 3,782 -6 -0.16 438 7.88 0.0338
2018-10-24 2018-09-30 13F Eli Lilly COM 532457108 3,788 888 30.62 406 64.37 0.0284
2018-08-14 2018-06-30 13F Eli Lilly COM 532457108 2,900 0 0.00 247 10.27 0.0193
2018-05-01 2018-03-31 13F Eli Lilly COM 532457108 2,900 -370 -11.31 224 -18.84 0.0173
2018-02-02 2017-12-31 13F Eli Lilly COM 532457108 3,270 0 0.00 276 -1.43 0.0199
2017-11-13 2017-09-30 13F Eli Lilly COM 532457108 3,270 0 0.00 280 4.09 0.0206
2017-08-09 2017-06-30 13F Eli Lilly COM 532457108 3,270 0 0.00 269 -2.18 0.0199
2017-05-15 2017-03-31 13F Eli Lilly COM 532457108 3,270 3,270 275 0.0214
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.